ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1416

Ultrasound (US)-guided Core-needle Biopsy (CNB) of the Non-swollen Parotid Gland: A Feasible and Well-tolerated Technique for Diagnosing and Stratifying Sjögren’s Disease (SjD)

Helena Achten1, Eva Genbrugge2, David Creytens2, Amber Vanhaecke3, Kristel De Boeck2, Dirk Elewaut4 and Isabelle Peene2, 1Ghent University, Merelbeke, Belgium, 2Ghent University, Ghent, Belgium, 3Ghent University, Ghent, Oost-Vlaanderen, Belgium, 4Ghent University and VIB Center for Inflammation Research, Ghent, Belgium

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Sjögren's syndrome, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Sjögren's Syndrome – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Histopathology remains a cornerstone in the diagnostic workup of Sjögren’s disease (SjD). Ultrasound (US)-guided core needle biopsy (CNB) of the parotid gland has emerged as a valuable alternative for obtaining salivary gland tissue for diagnostic purposes. This study aimed to assess the feasibility and tolerance of US guided CNB in a large cohort of suspected and confirmed SjD patients without salivary gland swelling, and to explore its role in SjD diagnosis and patient stratification.

Methods: 66 patients from the Belgian Sjögren’s Syndrome Transition Trial (BeSSTT) without salivary gland swelling underwent US guided CNB of the parotid gland. US was evaluated by Omeract and Hocevar scores. FS was calculated. Immunohistochemistry was performed (anti-CD20, anti-CD3, anti-CD138, anti-CD21, anti-Bcl-6, anti-CK, anti-FcRL4).

Results: First, CNB was well-tolerated and patients were willing to repeat the procedure. Second, CNB reliably provided sufficient salivary gland tissue to calculate FS in most cases (56/66). Even when too little salivary gland tissue was obtained (6/66), other SjD related parameters (Follicular dendritic cells, B cell predominance, increase in plasma cells, Lymphoepithelial lesions) allowed for biopsy evaluation. Third, US was significantly associated with both FS and the other SjD related features. A Hocevar score of less than 20 consistently indicated negative biopsy results. Remarkably, SjD patients showed a wide variety of histological findings, ranging from mild to severe parotid gland involvement, despite having similar clinical characteristics. Pre-clinical MALT lymphoma was observed in three cases, all with maximum US scores.

Conclusion: US guided CNB is well-tolerated and feasible, enhancing its utility in diagnosing SjD and stratifying patients. CNB facilitates the identification of homogeneous patient cohorts and offers a feasible endpoint for clinical trials. Furthermore, it serves as a minimally burdensome method to detect pre-clinical MALT lymphoma within the window of opportunity for immune intervention.

Supporting image 1

Association between histological findings and ultrasonography, SjD diagnosis and biopsy quality.


Disclosures: H. Achten: None; E. Genbrugge: None; D. Creytens: None; A. Vanhaecke: None; K. De Boeck: None; D. Elewaut: None; I. Peene: None.

To cite this abstract in AMA style:

Achten H, Genbrugge E, Creytens D, Vanhaecke A, De Boeck K, Elewaut D, Peene I. Ultrasound (US)-guided Core-needle Biopsy (CNB) of the Non-swollen Parotid Gland: A Feasible and Well-tolerated Technique for Diagnosing and Stratifying Sjögren’s Disease (SjD) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/ultrasound-us-guided-core-needle-biopsy-cnb-of-the-non-swollen-parotid-gland-a-feasible-and-well-tolerated-technique-for-diagnosing-and-stratifying-sjogrens-disease-sjd/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-us-guided-core-needle-biopsy-cnb-of-the-non-swollen-parotid-gland-a-feasible-and-well-tolerated-technique-for-diagnosing-and-stratifying-sjogrens-disease-sjd/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology